MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

MSD's confidence in its anti-TL1A antibody tulisokibart in inflammatory diseases has been made apparent by a decision to start trials of the drug in three more indications. Already in phase 3 testing ...

So, you like games? Vulture’s Movies Fantasy League just kicked off its new season. It’s fun, it’s free, and there are some killer prizes on the line. Sign up to play here, or learn more at the MFL ...

Due to many services interfering with or blocking the download, your Windows 11 language pack download can get stuck. To temporarily turn off those components, you can boot in the clean boot mode and ...

It was already clear that Max Verstappen was an F1 superstar in the making and after his first World title triumph in 2021, Red Bull made sure to tie their star asset down to a mega six-year contract, ...